Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Single Relapse of Multiple Sclerosis”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Ended earlyNCT03085810
What this trial is testing

Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Hoffmann-La Roche 1,225
Not applicableStudy completedNCT01485003
What this trial is testing

Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 231
Large-scale testing (Phase 3)Study completedNCT00666887
What this trial is testing

Minocycline in Clinically Isolated Syndromes (CIS)

Who this might be right for
Clinically Isolated SyndromesEarly Single Relapse of Multiple Sclerosis
Dr. Luanne Metz 142

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation